A healthy day of trading for Canadian cannabis stocks led the North American Marijuana Index to gain several points over Monday’s 169.07 close.
The Marijuana Index, which covers leading cannabis investments on both sides of the Canada-U.S. border, rose 7% on Monday to close at 174.82.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 11% in August.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 11% in July. This marks the first positive month for the North American Index since January.
Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 3% in June as continued losses in Canada closed out the Index’s second worst performing quarter since its inception in January 2015.
The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 15% in May as stocks sold off in both markets. This marks the worst performing month for the North American Marijuana Index since December 2015.
First Trust Portfolios filed an S-6 on May 3oth with the Securities and Exchange Commission for a Medical Cannabis Portfolio Series – FT 6766 that is seeking above average capital appreciation.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 9% in April due primarily to heavy losses in the United States.
On Thursday, April 13, 2017, Canada made headlines with its official introduction of legislation to legalize recreational cannabis in the country by July 2018. While the country’s announcement has major national and international implications, cannabis stocks in Canada took a downturn upon hearing the news.
While the Canadian Marijuana Index dipped slightly in March due to federal uncertainties, the Canadian public markets have bounced back today on the news of recreational marijuana legislation being introduced in Canada’s House of Commons this Thursday, April 13, 2017.
Attorney General Jeff Sessions issued a memo on April 5, 2017, outlining the mission of the U.S. Department of Justice’s Task Force on Crime Reduction and Public Safety, including the creation of a subcommittee to review marijuana enforcement policies, and it did not go unnoticed by public market participants.
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 2% in March as losses in Canada overtook modest gains in the U.S.
In this survey we will be reviewing the stocks that make up the North American Marijuana Index. In Part 1, we’ll look at Canopy Growth Corp. (OTCPK:TWMJF), GW pharmaceuticals (NASDAQ:GWPH), Axim Biotechnologies Inc. (OTCQB:AXIM), and United Cannabis Corp. (OTCQB:CNAB).
Major cannabis stock indices have been falling for three consecutive weeks, ever since White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized.
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
The cannabis industry’s excitement is building as the California takes steps towards establishing its legal recreational market. This week Los Angeles voters approved Measure M to create regulations for adult-use marijuana, thus setting up the city to steal the title of marijuana capital from Denver.
While President Donald Trump vowed on his campaign trail to let states decide the fate of marijuana legalization, recent comments by the Trump Administration seem to negate his campaign promise and have created a ripple effect in the public cannabis markets.
Marijuana stocks are riding high as the stock index is up for the eighth consecutive week.
Marijuana Index Review for 2017, United States and Canada Medical Cannabis Market website and it’s different features for stocks, and my input on investing.
Innovative Industrial Properties, Inc. (IIPR) is one of the latest and most notable companies focusing on marijuana to hit the markets, and the company had a fairly quiet IPO on Thursday, December 1.
For investors, the rising prospects of legalized pot may be too good to pass up, yet the publicly traded cannabis companies may not be such a smart bet.
On May 24, 2016, MassRoots (OTCQB: MSRT), a social media app for cannabis enthusiasts, announced that NASDAQ denied the company’s application for listing on the NASDAQ Capital Market, which had been filed back in August 2015.
Viridian Capital Advisors today released its 2015 Cannabis Industry Report and Stock Index.
Whether you are already an active investor in marijuana-based industries or just taking notes from the sidelines, chances are you don’t need me to tell you that the business is becoming fast and furious.
SAN DIEGO, May 16, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its portfolio company, HempMeds(TM), is exhibiting at the American Academy of Anti-Aging Medicine (A4M) Orlando World Congress May 16-17. A continuing medical education (CME) course on cannabidiol (CBD) will be offered by a licensed Medical Doctor to…
Solanbridge Group Inc crosses over to the marijuana sector, with a focus on CBD technology.
Tweed Marijuana Inc.’s net proceeds from the Offering will be utilized for corporate purposes.
Cannabinoid research company, Cannabis Therapy Corp., is expected to present at an upcoming cannabis summit in Denver.
Canadian-based investors, junior miners, are looking to invest within the medical marijuana space.
MySkin, Inc recently announced its emergence into the marijuana sector and their partnership with Nevada-based liability company.
All is well for GreenBank Capital, as they recently announced their entrance into the MMJ sector. Shares have risen and are predicted to harbor a similar flow of action in years to come.
B.C. investors be forewarned about the green rush: the budding marijuana enterprise holds some inconspicuous business scams.
The financials behind the marijuana industry is undoubtedly lucrative, but just how lucrative exactly?
With a rise in growing rights for licensed companies, the legal barriers regarding the cultivation and distribution of marijuana are slowly burning down.
A recent press release from The Wall Street Journal indicates that Tweed Marijuana Inc. has served to clarify investor concerns regarding the company’s shares.
Nearly a week ago, the SEC put a heavy limitation on trading shares of GrowLife (PHOT), which is expected to last until April 25th.
With development for proprietary technology within the legal marijuana trade underway, the industry is looking forward.
More money? No problem. Greengro Technologies moves their business forward with a significant increase in proceeds.
The Marijuana Index has some changes underway–keep calm and invest on.
Small cap marijuana stocks are popping up left, right and faster than a stoner shoveling down a slice of pizza.
Up-to-date information regarding the marijuana stock index is just a click away!
The index is managed and tracked by marijuanaindex.org
Look out for the 21 companies listed on the marijuana stock index.